Quancheng Kan
- Molecular Biology
- Biomedical Engineering top 10%
- Oncology top 10%
- Biomaterials top 5%
- Materials Chemistry
- Co-authors
- Zujiang YuZhenfeng DuanHuirong ShiFrancis J. HornicekLiangjie HongShichao SunRanran SunZhengwei Mao
- Topics
- Cancer-related Molecular Pathways (7 papers)RNA modifications and cancer (4 papers)Ubiquitin and proteasome pathways (3 papers)
- Cited by
- BiomaterialsOncologyCancer Research
- Partner nations
- ChinaUnited States
In The Last Decade
Quancheng Kan
30 papers receiving 1.2k citations
Hit Papers
Peers
Comparison fields: 5 of 104
- Molecular Biology 486
- Biomedical Engineering 352
- Oncology 350
- Biomaterials 225
- Materials Chemistry 206
Countries citing papers authored by Quancheng Kan
This map shows the geographic impact of Quancheng Kan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Quancheng Kan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Quancheng Kan more than expected).
Fields of papers citing papers by Quancheng Kan
This network shows the impact of papers produced by Quancheng Kan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Quancheng Kan. The network helps show where Quancheng Kan may publish in the future.
Co-authorship network of co-authors of Quancheng Kan
This figure shows the co-authorship network connecting the top 25 collaborators of Quancheng Kan. A scholar is included among the top collaborators of Quancheng Kan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Quancheng Kan. Quancheng Kan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 9 | |
| 2 | 1 | |
| 3 | 1 | |
| 4 | 13 | |
| 5 | 1 | |
| 6 | 29 | |
| 7 | 18 | |
| 8 | 43 | |
| 9 | 54 | |
| 10 | 17 | |
| 11 | 15 | |
| 12 | 2 | |
| 13 | 88 | |
| 14 | 13 | |
| 15 | 37 | |
| 16 | 5 | |
| 17 | 15 | |
| 18 | 5 | |
| 19 | 52 | |
| 20 | 49 |
About Quancheng Kan
Quancheng Kan is a scholar working on Oncology, Anesthesiology and Pain Medicine and Toxicology, having authored 30 papers that have together received 1.2k indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (7 papers), RNA modifications and cancer (4 papers) and Ubiquitin and proteasome pathways (3 papers). The work is most often cited by research in Biomaterials (225 citations), Oncology (350 citations) and Cancer Research (130 citations). Quancheng Kan has collaborated with scholars based in China and United States. Frequent co-authors include Zujiang Yu, Zhenfeng Duan, Huirong Shi, Francis J. Hornicek, Liangjie Hong, Shichao Sun, Ranran Sun, Zhengwei Mao, Ang Li and Guangying Cui. Their work appears in journals such as Advanced Materials, Scientific Reports and Experimental Cell Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.